Published in CMAJ on January 23, 2001
Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ (2010) 2.89
Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer (2013) 1.62
Reliability and validity of the AGREE instrument used by physical therapists in assessment of clinical practice guidelines. BMC Health Serv Res (2005) 1.49
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ (2004) 1.46
Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv (2010) 1.34
Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials (2009) 1.27
Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ (2001) 1.19
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd (2013) 1.14
Surgical management of early stage invasive breast cancer: a practice guideline. Can J Surg (2005) 1.12
Breast cancer-related lymphedema: women's experiences with an underestimated condition. Can Fam Physician (2005) 1.07
Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer (2010) 1.05
Management of secondary lymphedema related to breast cancer. Can Fam Physician (2010) 0.99
Low-level laser therapy in management of postmastectomy lymphedema. Lasers Med Sci (2006) 0.93
The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema. Support Care Cancer (2010) 0.92
Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol (2013) 0.91
Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedema. Support Care Cancer (2013) 0.90
The efficacy of manual lymphatic drainage therapy in the management of limb edema secondary to reflex sympathetic dystrophy. Rheumatol Int (2008) 0.88
Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer (2006) 0.86
Shoulder Mobility, Muscular Strength, and Quality of Life in Breast Cancer Survivors with and without Tai Chi Qigong Training. Evid Based Complement Alternat Med (2013) 0.85
Effect of acute exercise on upper-limb volume in breast cancer survivors: a pilot study. Physiother Can (2009) 0.82
Lymphatic pump treatment repeatedly enhances the lymphatic and immune systems. Lymphat Res Biol (2013) 0.82
Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol (2013) 0.81
Lymphangiosarcoma of the arm presenting with lymphedema in a woman 16 years after mastectomy: a case report. Cases J (2009) 0.81
Effect of complete decongestive therapy and a home program for patients with post mastectomy lymphedema. J Phys Ther Sci (2015) 0.79
Association between lymphedema self-care adherence and lymphedema outcomes among women with breast cancer-related lymphedema. Am J Phys Med Rehabil (2015) 0.79
The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Support Care Cancer (2004) 0.78
Clinical characteristics of patients with cancer referred for outpatient physical therapy. Phys Ther (2014) 0.77
Late effects of cancer and cancer treatment-the perspective of the patient. Support Care Cancer (2015) 0.77
Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer. Cancer Res Treat (2016) 0.76
Keeping breast cancer guidelines current. CMAJ (2001) 0.75
The effect of combined decongestive therapy and pneumatic compression pump on lymphedema indicators in patients with breast cancer related lymphedema. Iran Red Crescent Med J (2012) 0.75
The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients with Lymphedema. PLoS One (2015) 0.75
Oral health-related complications of breast cancer treatment: assessing dental hygienists' knowledge and professional practice. J Dent Hyg (2014) 0.75
Role of physiotherapy and patient education in lymphedema control following breast cancer surgery. Ther Clin Risk Manag (2015) 0.75
A Scoring System to Predict Arm Lymphedema Risk for Individual Chinese Breast Cancer Patients. Breast Care (Basel) (2016) 0.75
SELF-REPORTED MANAGEMENT OF BREAST CANCER-RELATED LYMPHOEDEMA. J Lymphoedema (2007) 0.75
Effects of matrix rhythm therapy on primary lymphedema: a case report. J Phys Ther Sci (2016) 0.75
The health of women treated for breast cancer: A challenge in primary care. Australas Med J (2012) 0.75
Efficacy of night-time compression for breast cancer related lymphedema (LYNC): protocol for a multi-centre, randomized controlled efficacy trial. BMC Cancer (2016) 0.75
Oral Health-Related Complications of Breast Cancer Treatment: Assessing Dental Hygienists' Knowledge and Professional Practice. J Dent Hyg (2015) 0.75
Efficacy and safety of far infrared radiation in lymphedema treatment: clinical evaluation and laboratory analysis. Lasers Med Sci (2017) 0.75
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Streptococcal infections of skin and soft tissues. N Engl J Med (1996) 4.78
Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1989) 3.78
Risk of lymphoedema following the treatment of breast cancer. Br J Surg (1986) 2.73
Incidence of breast carcinoma-related lymphedema. Cancer (1998) 2.71
Treatment of lymphedema. Lymphology (1994) 2.33
Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med (1992) 2.32
The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology Executive Committee. Lymphology (1995) 2.13
Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology (1991) 2.13
Effective treatment of lymphedema of the extremities. Arch Surg (1998) 2.11
Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol (1998) 1.79
Measuring and representing peripheral oedema and its alterations. Lymphology (1994) 1.74
The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer (1993) 1.74
Effects of compression bandaging with or without manual lymph drainage treatment in patients with postoperative arm lymphedema. Lymphology (1999) 1.68
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med (1999) 1.63
Arm problems and psychological distress after surgery for breast cancer. Can J Surg (1993) 1.61
Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med (1986) 1.57
Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer (1998) 1.51
Sequential pneumatic compression for lymphedema. A controlled trial. Arch Surg (1985) 1.48
Conservative treatment of postmastectomy lymphedema: a controlled, randomized trial. Ann Oncol (1991) 1.44
Axillary lymph nodes and breast cancer: a review. Cancer (1995) 1.42
The lymphedema chaos: a lancet. Ann Plast Surg (1989) 1.34
Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study. Eur J Cancer (1998) 1.34
Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. N Engl J Med (1993) 1.31
Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol (1993) 1.26
Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage--a randomized study. Acta Oncol (2000) 1.26
Non-group A beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromise. Am J Med (1985) 1.24
Lymphedema following the surgical treatment of breast cancer: a review of pathophysiology and treatment. J Pain Symptom Manage (1992) 1.14
Effects of treatment with an elastic sleeve and intermittent pneumatic compression in post-mastectomy patients with lymphoedema of the arm. Scand J Rehabil Med (1984) 1.14
Postoperative lymphoedema after treatment of breast cancer. Acta Chir Scand (1983) 1.13
A review of measures of lymphedema. Cancer (1998) 1.10
Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer (1998) 1.10
Postmastectomy lymphedema. Am J Surg (1955) 1.09
Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys (1986) 1.07
Incidence of arm swelling following axillary clearance for breast cancer. Br J Surg (1992) 1.06
Sequelae of axillary dissection vs. axillary sampling with or without irradiation for breast cancer. A randomized trial. Acta Chir Scand (1989) 1.06
Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) (1997) 1.05
Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol (2000) 1.04
Post-mastectomy lymphoedema treatment and measurement. Med J Aust (1994) 1.01
A randomized study comparing manual lymph drainage with sequential pneumatic compression for treatment of postoperative arm lymphedema. Lymphology (1998) 1.00
Focused review: postmastectomy lymphedema. Arch Phys Med Rehabil (1996) 0.99
Surgical approach to lymphedema of the arm after mastectomy. Am J Surg (1984) 0.99
Causes and treatment of post-mastectomy lymphedema of the arm. Report of 114 cases. JAMA (1962) 0.99
Postmastectomy lymphedema: late results of treatment in 385 patients. Arch Phys Med Rehabil (1972) 0.98
Evaluation of the results of three different methods of postmastectomy lymphedema treatment. J Surg Oncol (1984) 0.98
Selection of patients with lymphedema for compression therapy. Am J Surg (1977) 0.96
Factors that influence the incidence of brachial oedema after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg (1992) 0.94
Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg (1998) 0.94
Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. Int J Radiat Oncol Biol Phys (1986) 0.93
Long-term results of compression treatment for lymphedema. J Vasc Surg (1992) 0.93
Treatment of chronic postmastectomy lymphedema with low level laser therapy: a 2.5 year follow-up. Lymphology (1998) 0.92
Treatment of adult lower extremity lymphedema with the Wright linear pump: statistical analysis of a clinical trial. Arch Phys Med Rehabil (1988) 0.92
The role of pneumatic compression in the treatment of postmastectomy lymphedema. A randomized phase III study. Ann Oncol (1998) 0.91
Complex physical therapy for the lymphoedematous arm. J Hand Surg Br (1992) 0.90
Computed tomography in the assessment of response to limb compression in unilateral lymphoedema. Clin Radiol (1995) 0.89
Lymphedema: the seemingly forgotten complication. J Pain Symptom Manage (1994) 0.88
Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther (1998) 0.88
Omental transposition in primary lymphedema. Surg Gynecol Obstet (1967) 0.86
A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs. Br J Plast Surg (1988) 0.86
Clinical incidence of lymphoedema in breast cancer patients in Jönköping County, Sweden. Eur J Cancer Care (Engl) (1996) 0.83
Postmastectomy lymphedema treated with the Wright linear pump. Can J Surg (1987) 0.83
Effects of energy-matched pulsed and continuous ultrasound on tumor growth in mice. Phys Ther (1998) 0.81
Microwave heating in the management of postmastectomy upper limb lymphedema. Ann Plast Surg (1996) 0.81
Lymphedema initiated by aircraft flights. Aviat Space Environ Med (1996) 0.81
Effects of continuous therapeutic ultrasound on growth and metastasis of subcutaneous murine tumors. Phys Ther (1995) 0.80
The primary, secondary, and tertiary nursing interventions of lymphedema. Cancer Nurs (1985) 0.80
Effectiveness of modified Complex Physical Therapy for lymphoedema treatment. Aust J Physiother (1996) 0.78
Ultrasound therapy of chronic arm lymphedema after surgical treatment of breast cancer. Lymphology (1993) 0.78
Modern therapeutic approaches to postmastectomy brachial lymphedema. Microsurgery (1994) 0.78
Appraisal of myocutaneous flapping for treatment of postmastectomy lymphedema. Case report. Acta Chir Scand (1990) 0.78
An analysis of prognostic factors in response to conservative treatment of postmastectomy lymphedema. Surg Gynecol Obstet (1992) 0.78
Manual lymphatic drainage for chronic post-mastectomy lymphoedema treatment. Panminerva Med (1998) 0.78
Effectiveness of combined methods of physiotherapy for post-mastectomy lymphoedema. Scand J Rehabil Med (1980) 0.77
The prevention and management of lymphoedema after treatment for breast cancer. Int Rehabil Med (1981) 0.77
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 19.15
Differentiation of the "Intermediate" Coli-Like Bacteria. J Bacteriol (1942) 14.28
Differential Reactions in the Colon Group of Bacteria. Am J Public Health Nations Health (1934) 13.94
NOTES ON BACT. COLI AND BACT. AEROGENES. Am J Public Health (N Y) (1921) 9.89
The Effect of Metabolites of Escherichia coli on the Growth of Coli-Aerogenes Bacteria. J Bacteriol (1947) 9.43
Characteristics of Coli-like Microorganisms from the Soil. J Bacteriol (1917) 8.18
A phage P22 gene controlling integration of prophage. Virology (1967) 7.98
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med (1997) 7.61
Antibiotic Interrelationships among the Enteric Group of Bacteria. J Bacteriol (1947) 7.44
Immunological method for mapping genes on Drosophila polytene chromosomes. Proc Natl Acad Sci U S A (1982) 7.08
Cloning of herpes simplex virus type 1 sequences representing the whole genome. J Virol (1981) 5.66
Factors Affecting Germicidal Efficiency of Chlorine and Chloramine. Am J Public Health Nations Health (1944) 5.43
Regulation of even-skipped stripe 2 in the Drosophila embryo. EMBO J (1992) 4.63
Divergent homeo box proteins recognize similar DNA sequences in Drosophila. Nature (1988) 4.63
Nitrogen Availability as an Aid in the Differentiation of Bacteria in the Coli-Aerogenes Group. J Bacteriol (1938) 4.59
Some Factors Influencing the Germicidal Efficiency of Alkalies. Am J Public Health Nations Health (1928) 4.23
Some Observations on the Germicidal Efficiency of Chloramine-T and Calcium Hypochlorite. J Bacteriol (1935) 4.14
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45. J Virol (1984) 4.09
Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies. J Virol (1983) 4.04
The Facultative Sporulating Bacteria Producing Gas from Lactose. J Bacteriol (1937) 3.93
Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. J Mol Biol (1979) 3.88
SOME DIFFERENTIAL REACTIONS OF COLI-LIKE BACTERIA. Am J Public Health (N Y) (1917) 3.77
The graded distribution of the dorsal morphogen is initiated by selective nuclear transport in Drosophila. Cell (1989) 3.77
Diagnosis of iron-deficiency anemia in the elderly. Am J Med (1990) 3.77
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
Dif, a dorsal-related gene that mediates an immune response in Drosophila. Cell (1993) 3.68
Modulation of enhancer-promoter interactions by insulators in the Drosophila embryo. Nature (1995) 3.61
Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study. Breast Cancer Res Treat (2002) 3.53
Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell (1993) 3.46
The dorsal morphogen gradient regulates the mesoderm determinant twist in early Drosophila embryos. Genes Dev (1991) 3.45
The dorsal gradient morphogen regulates stripes of rhomboid expression in the presumptive neuroectoderm of the Drosophila embryo. Genes Dev (1992) 3.38
Characterization and localization of the even-skipped protein of Drosophila. EMBO J (1987) 3.29
Spatial regulation of Antennapedia and bithorax gene expression by the Polycomb locus in Drosophila. Cell (1986) 3.03
Sequence-specific DNA-binding activities of the gap proteins encoded by hunchback and Krüppel in Drosophila. Nature (1989) 2.97
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Mol Cell Biol (1981) 2.97
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay. J Virol (1983) 2.96
in vitro MORPHOGENESIS OF PHAGE P22 FROM HEADS AND BASE-PLATE PARTS. Proc Natl Acad Sci U S A (1967) 2.93
Regulation of a segmentation stripe by overlapping activators and repressors in the Drosophila embryo. Science (1991) 2.90
Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys (1994) 2.86
The dorsal morphogen is a sequence-specific DNA-binding protein that interacts with a long-range repression element in Drosophila. Cell (1991) 2.85
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J Virol (1984) 2.84
dorsal-twist interactions establish snail expression in the presumptive mesoderm of the Drosophila embryo. Genes Dev (1992) 2.76
The eve stripe 2 enhancer employs multiple modes of transcriptional synergy. Development (1996) 2.74
Homeo box genes of the Antennapedia and bithorax complexes of Drosophila. Cell (1985) 2.68
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA. Mol Cell Biol (1986) 2.65
Transcriptional regulation of a pair-rule stripe in Drosophila. Genes Dev (1991) 2.63
Interaction of short-range repressors with Drosophila CtBP in the embryo. Science (1998) 2.61
RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide. J Virol (1973) 2.58
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol (1987) 2.58
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis. Science (1987) 2.57
Local inhibition and long-range enhancement of Dpp signal transduction by Sog. Nature (1999) 2.56
Establishment of the mesoderm-neuroectoderm boundary in the Drosophila embryo. Science (1991) 2.56
Spatial distribution of Antennapedia transcripts during Drosophila development. EMBO J (1983) 2.50
A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer (1996) 2.49
Regulation of two pair-rule stripes by a single enhancer in the Drosophila embryo. Dev Biol (1996) 2.42
Different core promoters possess distinct regulatory activities in the Drosophila embryo. Genes Dev (1998) 2.38
Characterization of a notochord-specific enhancer from the Brachyury promoter region of the ascidian, Ciona intestinalis. Development (1997) 2.38
Short-range transcriptional repressors mediate both quenching and direct repression within complex loci in Drosophila. Genes Dev (1996) 2.36
Autoregulatory and gap gene response elements of the even-skipped promoter of Drosophila. EMBO J (1989) 2.36
Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions. CMAJ (1997) 2.30
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy. Ann Oncol (2008) 2.27
Spatially regulated expression of homeotic genes in Drosophila. Science (1985) 2.25
DIFFERENTIATION OF HUMAN AND SOIL STRAINS OF THE AEROGENES SECTION OF THE COLON GROUP. Am J Public Health (N Y) (1924) 2.25
Short-range repression permits multiple enhancers to function autonomously within a complex promoter. Genes Dev (1994) 2.24
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Complementary patterns of even-skipped and fushi tarazu expression involve their differential regulation by a common set of segmentation genes in Drosophila. Genes Dev (1987) 2.22
dCtBP mediates transcriptional repression by Knirps, Krüppel and Snail in the Drosophila embryo. EMBO J (1998) 2.22
Hydrogen Sulfide Production as a Differential Test in the Colon Group. J Bacteriol (1936) 2.22
Supplemental social services improve outcomes in public addiction treatment. Addiction (1998) 2.21
The Fab-7 element of the bithorax complex attenuates enhancer-promoter interactions in the Drosophila embryo. Genes Dev (1996) 2.16
Regulation of Antennapedia transcript distribution by the bithorax complex in Drosophila. Nature (1984) 2.16
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product. Mol Cell Biol (1983) 2.15
A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ (2001) 2.11
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev (1988) 2.11
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli. J Infect Dis (1983) 2.08
The substrate-facilitated transport of the glucose carrier across the human erythrocyte membrane. Biochim Biophys Acta (1965) 2.05
New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med (1986) 2.05
Gap genes define the limits of antennapedia and bithorax gene expression during early development in Drosophila. EMBO J (1988) 2.02
Cross-regulatory interactions among pair-rule genes in Drosophila. Science (1986) 1.98
Human DNA sequences homologous to a protein coding region conserved between homeotic genes of Drosophila. Cell (1984) 1.98
Theory of the electrokinetic behavior of human erythrocytes. Biophys J (1983) 1.97
Transcriptional repression in development. Curr Opin Cell Biol (1996) 1.96
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol (1988) 1.94
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infect Immun (1978) 1.93
CONCENTRATION OF GLUCOSE AND LACTOSE AND VIABILITY OF COLI-LIKE BATERIA. Am J Public Health (N Y) (1918) 1.91
Gene order in prophage P22. Virology (1965) 1.91
Method for induction of mutations in physically defined regions of the herpes simplex virus genome. J Virol (1981) 1.89
Conversion of a dorsal-dependent silencer into an enhancer: evidence for dorsal corepressors. EMBO J (1993) 1.88
Mutually repressive interactions between the gap genes giant and Krüppel define middle body regions of the Drosophila embryo. Development (1991) 1.88
New insights into the physiology and pharmacology of vitamin C. CMAJ (2001) 1.87
Autoregulation of a segmentation gene in Drosophila: combinatorial interaction of the even-skipped homeo box protein with a distal enhancer element. Genes Dev (1991) 1.87
Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst (1996) 1.86
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity. Cell (1988) 1.84
GAGA mediates the enhancer blocking activity of the eve promoter in the Drosophila embryo. Genes Dev (1998) 1.83
Two homoeo box loci mapped in evolutionarily related mouse and human chromosomes. Nature (1985) 1.81
Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect Immun (1994) 1.79
Spatial regulation of the gap gene giant during Drosophila development. Development (1991) 1.79